Back

Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease Revascularisation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Muhammad Abdur Rauf

Kuwait Teaching Hospital Peshawar, Peshawar (Pakistan)

6 More presentations in this session

Presentation thumbnail
Discussant - Expanding pharmacological and non-pharmacological options for coronary disease
Presentation thumbnail
The effectiveness of allopurinol in improving ischemic symptoms or exercise tolerance in patients with chronic coronary syndromes: a systematic review and meta-analysis of randomized clinical trials
Doctor S. Del Vecchio Ziotti (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Impact of nebivolol versus carvedilol on long-term clinical outcomes in STEMI patients treated with drug-eluting stents
Slides Video
Presentation thumbnail
Baseline characteristics, treatment and mortality among acute myocardial infarction patients with varying left ventricular ejection fractions according to the Estonian Myocardial Infarction Registry
Doctor J. Smirnova (Tartu, EE)
Abstract
Presentation thumbnail
Preliminary experience with comprehensive treatment in patients with rapidly progressive coronary artery disease (RP-CAD)
Doctor Y. Liu (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Expanding pharmacological and non-pharmacological options for coronary disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis
thumbnail
Congress Presentation
TADCLOT- Twice A Day CLOpidogrel vs. Ticagrelor post STEMI
thumbnail
Congress Presentation
Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources